JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Capello, A.
Right arrow Articles by de Jong, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capello, A.
Right arrow Articles by de Jong, M.

Peptide Receptor Radionuclide Therapy In Vitro Using [111In-DTPA0]Octreotide

Astrid Capello, MD, Eric P. Krenning, PhD, Wout A.P. Breeman, PhD, Bert F. Bernard and Marion de Jong, PhD

Department of Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands



View larger version (17K):

[in a new window]
 
FIGURE 1. Internalization in CA20948 cells after 1-h incubation at 37°C with [111In-DTPA0]octreotide and 111In-DTPA. Bars represent mean ± SEM.

 


View larger version (38K):

[in a new window]
 
FIGURE 2. Amount of internalized [111In-DTPA0]octreotide after 72 h in growth medium with 200–10,000 cells per well. Cells were incubated for 1 h at 37°C with increasing concentrations of [111In-DTPA0]octreotide. Amount of internalized [111In-DTPA0]octreotide was determined after 72 h. (A) Amount of internalized counts per minute. (B) Internalized amount presented as percentage of given dose. Bars represent mean ± SEM.

 


View larger version (26K):

[in a new window]
 
FIGURE 3. Effects of incubation time, concentration, and specific activity of [111In-DTPA0]octreotide on cell survival of CA20948 cells after PRRT. Cells were incubated for 1, 3, and 5 h with 0.37 or 3.7 MBq [111In-DTPA0]octreotide at 37°C using 2 different specific activities (specific activity of B is different from that of A and C). Bars represent mean ± SEM.

 


View larger version (18K):

[in a new window]
 
FIGURE 4. Inhibitory effect of [111In-DTPA0]octreotide on clonogenic cell survival of rat pancreatic tumor cell line CA20948. Cells were incubated for 1 h at 37°C with increasing amount of [111In-DTPA0]octreotide. Bars represent mean ± SEM.

 


View larger version (22K):

[in a new window]
 
FIGURE 5. Effect of 111In-DTPA (A) and octreotide (B) on clonogenic cell survival of CA20948 cells. Cells were incubated for 1 h in increasing amount of 111In-DTPA (same amount was given as was used with [111In-DTPA]octreotide [Fig. 4]). Amount of radioactivity that is normally attached to cells was added to medium after 1-h incubation. 111In-DTPA was also added when medium was refreshed after 3 d. Bars represent mean ± SEM.

 


View larger version (23K):

[in a new window]
 
FIGURE 6. Inhibitory effect of octreotide on tumor cell survival of CA20948 cell line. Cells were incubated for 1 h at 37°C with 10-6 mol/L octreotide (second bar from left) and cells were incubated with 10-6 mol/L octreotide plus increasing amount of [111In-DTPA]octreotide (third to fifth bars from left). Bars represent mean ± SEM.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.